194 related articles for article (PubMed ID: 12503625)
1. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.
Gagne A; Banks P; Hurt SD
J Recept Signal Transduct Res; 2002; 22(1-4):333-43. PubMed ID: 12503625
[TBL] [Abstract][Full Text] [Related]
2. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors.
Banks P; Gosselin M; Prystay L
J Biomol Screen; 2000 Oct; 5(5):329-34. PubMed ID: 11080691
[TBL] [Abstract][Full Text] [Related]
3. Determination of equilibrium dissociation constants in fluorescence polarization.
Prystay L; Gosselin M; Banks P
J Biomol Screen; 2001 Jun; 6(3):141-50. PubMed ID: 11689110
[TBL] [Abstract][Full Text] [Related]
4. Development of a homogeneous high throughput fluorescence polarization assay for G protein-coupled receptor binding.
Lee PH; Bevis DJ
J Biomol Screen; 2000 Dec; 5(6):415-19. PubMed ID: 11598459
[TBL] [Abstract][Full Text] [Related]
5. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
6. Single-molecule detection technologies in miniaturized high throughput screening: binding assays for g protein-coupled receptors using fluorescence intensity distribution analysis and fluorescence anisotropy.
Rüdiger M; Haupts U; Moore KJ; Pope AJ
J Biomol Screen; 2001 Feb; 6(1):29-37. PubMed ID: 11679163
[TBL] [Abstract][Full Text] [Related]
7. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
Harris A; Cox S; Burns D; Norey C
J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
[TBL] [Abstract][Full Text] [Related]
8. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors.
Allen M; Reeves J; Mellor G
J Biomol Screen; 2000 Apr; 5(2):63-9. PubMed ID: 10803605
[TBL] [Abstract][Full Text] [Related]
9. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.
Huwiler KG; De Rosier T; Hanson B; Vogel KW
Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence polarization assays for high throughput screening of G protein-coupled receptors.
Banks P; Gosselin M; Prystay L
J Biomol Screen; 2000 Jun; 5(3):159-68. PubMed ID: 10894759
[TBL] [Abstract][Full Text] [Related]
11. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.
Parker GJ; Law TL; Lenoch FJ; Bolger RE
J Biomol Screen; 2000 Apr; 5(2):77-88. PubMed ID: 10803607
[TBL] [Abstract][Full Text] [Related]
12. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
13. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules.
Smith DS; Eremin SA
Anal Bioanal Chem; 2008 Jul; 391(5):1499-507. PubMed ID: 18264817
[TBL] [Abstract][Full Text] [Related]
16. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.
Alquicer G; Sedlák D; Byun Y; Pavlícek J; Stathis M; Rojas C; Slusher B; Pomper MG; Bartunek P; Barinka C
J Biomol Screen; 2012 Sep; 17(8):1030-40. PubMed ID: 22751730
[TBL] [Abstract][Full Text] [Related]
18. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled receptor microarrays.
Fang Y; Frutos AG; Lahiri J
Chembiochem; 2002 Oct; 3(10):987-91. PubMed ID: 12362364
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
